DA
Danielle Antalffy UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
36
Avg Return
Past Year
Past Year
3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
36.4%
Neutral
54.5%
Negative
9.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Communication Equipment
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $102 |
0%
downside
| 1 | – |
–
| 19 Nov ‘25 15 days ago |
|
|
|
Buy
Upgraded
| $400 |
29%
upside
| 1 | -6.8% |
0
%
| 19 Nov ‘25 15 days ago |
|
|
|
Neutral
Maintained
| $5.85 |
113%
upside
| 1 | – |
–
| 7 Nov ‘25 27 days ago |
|
|
|
Sell
Maintained
| $88 |
5%
downside
| 1 | +2.6% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Neutral
Maintained
| $16 |
11%
upside
| 1 | – |
–
| 6 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $95 |
48%
upside
| 1 | -12% |
0
%
| 3 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $21 |
13%
upside
| 1 | – |
–
| 31 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $600 |
6%
upside
| 1 | – |
–
| 23 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $140 |
43%
upside
| 1 | -2.2% |
0
%
| 23 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $214 |
6%
upside
| 1 | +11% |
0
%
| 14 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $89 |
34%
downside
| 1 | -39% |
0
%
| 22 Sep ‘25 2 months ago |
|